tiprankstipranks

William McVicar Insider Profile

4 Followers
William McVicar, Director at Decoy Therapeutics, holds 3.00K shares in Decoy Therapeutics (Ticker: DCOY), holds 0.00 shares in Rocket Pharmaceuticals (Ticker: RCKT).
tipranks
William McVicar

William McVicar
Decoy Therapeutics (DCOY)
Director

Ranked #29,812 out of 108,921 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+74.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$8K
100.00%
0.00%
A breakdown of William McVicar's holdings

Insider Roles

Decoy Therapeutics
(DCOY)
Director
Rocket Pharmaceuticals
(RCKT)
EVP, Chief Scientific OfficerExhibit ListExhibit 2
Roles that William McVicar holds in companies

Most Profitable Insider Trade

Stock:
Decoy Therapeutics
(DCOY)
Rating:Informative Buy
Date:Feb 12, 2020 - Feb 12, 2021
Return:+211.20%
The most profitable trade made by William McVicar

William McVicar's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Decoy Therapeutics
Sep 02, 2026
Director
Uninformative Buy
$8.20K
Rocket Pharmaceuticals
EVP, Chief Scientific OfficerExhibit ListExhibit 2
$0.00
List of latest transactions for each holding click on a transaction to see William McVicar's performance on stock

William McVicar insider profile FAQ

What is the percentage of profitable transactions made by William McVicar?
The percentage of profitable transactions made by William McVicar is 50%.
    What is the average return per transaction made by William McVicar?
    The average return per transaction made by William McVicar is 74.40%.
      What stocks does William McVicar hold?
      William McVicar holds: DCOY, RCKT stocks.
        What was William McVicar’s latest transaction?
        William McVicar latest transaction was an Uninformative Buy of ―.
          What was William McVicar's most profitable transaction?
          William McVicar’s most profitable transaction was an Informative Buy of DCOY stock on February 12, 2020. The return on the trade was 211.20%.
            What is William McVicar's role in Decoy Therapeutics?
            William McVicar's role in Decoy Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.